Venti-Trach Tracheostomy Tube (570 Series); Venti-Trach Tracheostomy Tube (571 Series); Venti-Trach Tracheostomy Tube (580 Series); Venti-Trach Tracheostomy Tube (581 Series)
Vitaltec Corporation · Decision date Sep 11, 2026
What did the FDA decide?
Vitaltec Corporation received a substantially equivalent (SESE) decision from the FDA on September 11, 2026, for the Venti-Trach Tracheostomy Tube, covering the 570, 571, 580 and 581 series. The submission, K253063, was received September 22, 2025, and is classified under regulation 868.5800 with product code BTO in the anesthesiology specialty. A SESE decision is a 510(k) clearance to market, not a premarket approval.
The FDA review letter states that the device has the same indications for use as the predicate, Rota-Trach Disposable, with small modifications, and that it raises no new questions of safety and effectiveness. The letter also references verification and validation against FDA-recognized standards, including ISO 5366:2016 and ISO 5356-1:2015. The available excerpts do not specify the modifications, the full standards list, or any clinical performance data, so those details remain unknown from this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253063
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Vitaltec Corporation
- Product code
- BTO
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tube, Tracheostomy (W/Wo Connector).
- Applicant
- Vitaltec Corporation
- Product code
- BTO
- FDA device class
- 2
FDA decision timeline
K253063 received
Application receipt date recorded by FDA.
K253063 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Vitaltec Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Taichung City
Sources and methodology
- Original FDA record: K253063
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records